Guidance on the risk assessment of substances present 1 in food intended for infants below 16 weeks of age 2 EFSA Scientific Committee

12 Following a request from the European Commission to the European Food Safety Authority (EFSA), 13 EFSA's Scientific Committee (SC) prepared a guidance for the risk assessment of substances present 14 in food intended for infants below 16 weeks of age. In its approach to develop this guidance, the 15 EFSA SC took into account, among others, (i) an exposure assessment based on infant formula as the 16 only source of nutrition; (ii) knowledge of organ development in human infants, including the 17 development of the gut, metabolic and excretory capacities, the brain and brain barriers, the immune 18 system, the endocrine and reproductive systems; (iii) the overall toxicological profile of the substance 19 identified through the standard toxicological tests, including critical effects; (iv) the relevance for the 20 human infant of the neonatal experimental animal models used. The EFSA SC notes that during the 21 period from birth up to 16 weeks, infants are expected to be exclusively fed on breast milk and/or 22 infant formula. The EFSA SC views this period as the time where health-based guidance values for the 23 general population do not apply without further considerations. High infant formula consumption per 24 body weight is derived from 95 percentile consumption. The first weeks of life is the time of the 25 highest relative consumption on a body weight basis. Therefore, when performing an exposure 26 assessment, the EFSA SC proposes to use the high consumption value of 260 mL/kg bw/day. A 27 decision tree approach is proposed that enables a risk assessment of substances present in food 28 intended for infants below 16 weeks of age. The additional information needed when testing 29 substances present in food for infants below 16 weeks of age and the approach to be taken for the 30 risk assessment are on a case-by-case basis, depending on whether the substance is added 31 intentionally to food and is systemically available. 32 © 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on 33 behalf of European Food Safety Authority. 34

[1]  S. Eyal,et al.  Imaging transporters: Transforming diagnostic and therapeutic development , 2016, Clinical pharmacology and therapeutics.

[2]  David Wang,et al.  The Bacterial Microbiome and Virome Milestones of Infant Development. , 2016, Trends in microbiology.

[3]  Jennifer H. Martin,et al.  Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future , 2015, British journal of clinical pharmacology.

[4]  M. Eldh,et al.  Breast Milk and Solid Food Shaping Intestinal Immunity , 2015, Front. Immunol..

[5]  J. Garssen,et al.  Deoxynivalenol Impairs Weight Gain and Affects Markers of Gut Health after Low-Dose, Short-Term Exposure of Growing Pigs , 2015, Toxins.

[6]  S. Donovan,et al.  Human Microbiota-Associated Swine: Current Progress and Future Opportunities , 2015, ILAR journal.

[7]  J. Marriott,et al.  Paediatric pharmacokinetics: key considerations. , 2015, British journal of clinical pharmacology.

[8]  K. Maloy,et al.  Modulation of immune development and function by intestinal microbiota. , 2014, Trends in immunology.

[9]  D. Tibboel,et al.  Drug metabolism for the paediatrician , 2014, Archives of Disease in Childhood.

[10]  P. Mannon,et al.  The Microbiota, the Immune System and the Allograft , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  C. Lebrilla,et al.  A peptidomic analysis of human milk digestion in the infant stomach reveals protein-specific degradation patterns. , 2014, The Journal of nutrition.

[12]  Thomas W. Jefferson,et al.  Reproductive toxicology. , 2022, Reproductive toxicology.

[13]  R. Ransohoff,et al.  Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.

[14]  L. Ferrarini,et al.  Wnt Activation of Immortalized Brain Endothelial Cells as a Tool for Generating a Standardized Model of the Blood Brain Barrier In Vitro , 2013, PloS one.

[15]  H. Clevers,et al.  Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications , 2013, Science.

[16]  S. Tzipori,et al.  A pig model of the human gastrointestinal tract , 2013, Gut microbes.

[17]  D. Tudehope,et al.  Nutritional needs of the micropreterm infant. , 2013, The Journal of pediatrics.

[18]  K. Krishnan,et al.  Assessing the impact of child/adult differences in hepatic first-pass effect on the human kinetic adjustment factor for ingested toxicants. , 2013, Regulatory toxicology and pharmacology : RTP.

[19]  Kuender D Yang,et al.  Influence and mechanisms of maternal and infant diets on the development of childhood asthma. , 2013, Pediatrics and neonatology.

[20]  Ruth R. Montgomery,et al.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. , 2012, Immunity.

[21]  A. Butler,et al.  The developing human preterm neonatal immune system: a case for more research in this area. , 2012, Clinical immunology.

[22]  S. Wenzel,et al.  Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma , 2012, Nature Medicine.

[23]  Akio Kawamura,et al.  Protein quantification of UDP-glucuronosyltransferases 1A1 and 2B7 in human liver microsomes by LC-MS/MS and correlation with glucuronidation activities , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  S. Khan,et al.  Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies , 2012, Critical reviews in toxicology.

[25]  M. Hornef,et al.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation , 2011, Nature Reviews Immunology.

[26]  P. Barrow,et al.  Reproductive System Including Studies in Juvenile Minipigs , 2011 .

[27]  A. Nowak‐Wegrzyn,et al.  Can Early Introduction of Egg Prevent Egg Allergy in Infants? A Population-Based Study , 2011, Pediatrics.

[28]  Paige L. Williams,et al.  Dioxin Exposure and Age of Pubertal Onset among Russian Boys , 2011, Environmental health perspectives.

[29]  G. Kearns,et al.  Developmental pharmacokinetics. , 2011, Handbook of experimental pharmacology.

[30]  J. Dubernard,et al.  [The kidney]. , 2011, Bulletin de l'Academie nationale de medecine.

[31]  C. Tuleu,et al.  Specific aspects of gastro-intestinal transit in children for drug delivery design. , 2010, International journal of pharmaceutics.

[32]  C. Metges,et al.  Nutritional programming of gastrointestinal tract development. Is the pig a good model for man? , 2010, Nutrition Research Reviews.

[33]  J. Ilonen,et al.  Age at the Introduction of Solid Foods During the First Year and Allergic Sensitization at Age 5 Years , 2010, Pediatrics.

[34]  O. Levy,et al.  Neonatal innate immunity in allergy development , 2009, Current opinion in pediatrics.

[35]  Sarah N. Taylor,et al.  Intestinal permeability in preterm infants by feeding type: mother's milk versus formula. , 2009, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[36]  R. Dietert Developmental immunotoxicity (DIT), postnatal immune dysfunction and childhood leukemia. , 2009, Blood cells, molecules & diseases.

[37]  K. Honda,et al.  Inefficient phagosome maturation in infant macrophages. , 2008, Biochemical and biophysical research communications.

[38]  P. Guilloteau,et al.  Control of development of gastrointestinal system in neonates. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[39]  M. Beck,et al.  Nonclinical Juvenile Toxicity Testing , 2008 .

[40]  Nancy G Doerrer,et al.  A tiered approach to life stages testing for agricultural chemical safety assessment. , 2007, Critical reviews in toxicology.

[41]  C. Chougnet,et al.  Defective antigen-presenting cell function in human neonates. , 2006, Clinical immunology.

[42]  David H. Chen,et al.  Immune System Maturity and Sensitivity to Chemical Exposure , 2006 .

[43]  C. Falany,et al.  Developmental Expression of Aryl, Estrogen, and Hydroxysteroid Sulfotransferases in Pre- and Postnatal Human Liver , 2006, Journal of Pharmacology and Experimental Therapeutics.

[44]  Walter Schmitt,et al.  A Mechanistic Approach for the Scaling of Clearance in Children , 2006, Clinical pharmacokinetics.

[45]  Susan L Makris,et al.  Developmental toxicology evaluations--issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  K Walton,et al.  Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[47]  Wilhelm Huisinga,et al.  Toxicokinetics and Metabolism , 2022 .

[48]  Michael S Kramer,et al.  The optimal duration of exclusive breastfeeding: a systematic review. , 2004, Advances in experimental medicine and biology.

[49]  V. V. van Hinsbergh,et al.  Intracellular signalling involved in modulating human endothelial barrier function , 2002, Journal of anatomy.

[50]  Harvey J. Clewell,et al.  Review and Evaluation of the Potential Impact of Age- and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry , 2002, Critical reviews in toxicology.

[51]  D. Tibboel,et al.  Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? , 2001, Journal of pediatric surgery.

[52]  F. P. Prince The triphasic nature of Leydig cell development in humans, and comments on nomenclature. , 2001, The Journal of endocrinology.

[53]  A. Olshan,et al.  Workshop to identify critical windows of exposure for children's health: cancer work group summary. , 2000, Environmental health perspectives.

[54]  N. Kawai,et al.  Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. , 1996, Journal of neurosurgery.

[55]  D. Lairon,et al.  Effect of Human Milk or Formula on Gastric Function and Fat Digestion in the Premature Infant1 , 1996, Pediatric Research.

[56]  A. Betz,et al.  Mechanisms of Sodium Transport at the Blood‐Brain Barrier Studied with In Situ Perfusion of Rat Brain , 1996, Journal of neurochemistry.

[57]  D. Ménard,et al.  Ontogeny of human gastric lipase and pepsin activities. , 1995, Gastroenterology.

[58]  T J Cole,et al.  Small intestinal length: a factor essential for gut adaptation. , 1991, Gut.

[59]  Habgood Barriers in the developing brain. , 1990 .

[60]  Diana Anderson In Vitro Models , 1990, Drug safety.

[61]  P J Kumar,et al.  The Exocrine Pancreas. , 1980 .

[62]  J. Sloper Pathologic Basis of Disease , 1980 .

[63]  G. Goldstein,et al.  Polarity of the blood-brain barrier: Distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells , 1980, Brain Research.

[64]  M. Gupta,et al.  Gastric retention in neonates. , 1978, Pediatrics.

[65]  B. Strandvik,et al.  BILE ACIDS AND PANCREATIC ENZYMES DURING ABSORPTION IN THE NEWBORN , 1972, Acta paediatrica Scandinavica.

[66]  J. Randolph,et al.  Gastric acidity in the first day of life. , 1966, Pediatrics.

[67]  E. Hoen [The gastrointestinal tract]. , 1961, Monatsschrift fur Kinderheilkunde.

[68]  Vinay Kumar,et al.  The Diseases of Infancy and Childhood , 1902, Buffalo Medical Journal.